Hims’ Super Bowl fallout, and the FDA reverses course

Share

1

Hims' Super Bowl advertisement has raised concerns among regulators regarding the marketing of pharmaceutical products.
2

The FDA may be lowering standards for the approval of psychedelic medicines, impacting future treatment options.
3

Moderna is currently navigating the FDA's guidance related to its influenza vaccine application.
4

Compass Pathways has released new clinical trial data concerning the use of psychedelics for treating depression.
5

Hims is expanding its services through the acquisition of telehealth company Eucalyptus and a focus on blood testing.